Open Access

ARTICLE

Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study

SUKRAN SENYUREK¹, SEZER SAGLAM^2,*, ESRA KAYTAN SAGLAM³, HAKAN YANAR⁴, KAAN GOK⁴, DIDEM TASTEKIN⁵, CANAN KOKSAL AKBAS⁶, NERGIZ DAGOGLU SAKIN³, GULBIZ DAGOGLU KARTAL⁷, EMRE BALIK⁸, METIN KESKIN⁴, YASEMIN SANLI⁹, MINE GULLUOGLU¹⁰, ZULEYHA AKGUN¹¹

1 Department of Radiation Oncology, Koc University School of Medicine, Istanbul, 34450, Türkiye
2 Department of Medical Oncology, Demiroglu Bilim University Faculty of Medicine, Istanbul, 34394, Türkiye
3 Department of Radiation Oncology, Istanbul University Oncology Institute, Istanbul, 34093, Türkiye
4 Department of General Surgery, Istanbul University Istanbul Faculty of Medicine, Istanbul, 34093, Türkiye
5 Department of Medical Oncology, Istanbul University Oncology Institute, Istanbul, 34093, Türkiye
6 Department of Medical Physics, Istanbul University Oncology Institute, Istanbul, 34093, Türkiye
7 Department of Radiology, Istanbul University Istanbul Faculty of Medicine, Istanbul, 34093, Türkiye
8 Department of General Surgery, Koc University School of Medicine, Istanbul, 34450, Türkiye
9 Department of Nuclear Medicine, Istanbul University Istanbul Faculty of Medicine, Istanbul, 34093, Türkiye
10 Department of Pathology, Istanbul University Istanbul Faculty of Medicine, Istanbul, 34093, Türkiye
11 Department of Radiation Oncology, Memorial Sisli Hospital, Istanbul, 34384, Türkiye

* Corresponding Author: SEZER SAGLAM. Email: